Evaluation of Optical Coherence Tomography Angiography Parameters Following Use of Ranibizumab Biosimilar in Branch Retinal Vein Occlusion. - NI

Maulana Azad Medical College0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•1. Treatment naïve patients in the age group of 45-65 years having branch retinal vein occlusion of less than three months duration along with macular edema(Central foveal thickness of =300 micrometers)
•2. Subjects having best corrected visual acuity of at least 6/60

•1. Patients having ocular conditions associated with accumulation of sub-retinal fluid or macular affection like diabetic retinopathy, polypoidal choroidal vasculopathy (PCV), ocular inflammations, age-related macular degeneration, pathologic myopia and angioid streaks
•2. Patients who have undergone any intraocular surgery other than uncomplicated cataract extraction
•3. Risk of thrombo-embolic events and/or occurrence of these within past 6 months

发起方